BMRN

BioMarin Pharmaceutical Inc. News Headlines

$69.85
*  
0.25
0.36%
Get BMRN Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading BMRN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Narrower-than-Expected Loss at Catalyst Pharma - Analyst Blog
3/20/2014 9:20:01 AM - Zacks.com

BioMarin Pharmaceutical Larger Than S&P 500 Component Newmont Mining
2/28/2014 5:51:19 PM - BNK Invest

Interesting BMRN Put And Call Options For October 18th
2/26/2014 12:39:59 PM - BNK Invest

Is NPS Pharmaceuticals The Next Alexion?
2/25/2014 9:56:00 AM - Seeking Alpha

BioMarin Rises on Favorable CHMP Opinion - Analyst Blog
2/21/2014 4:05:01 PM - Zacks.com

Strong 2014 Sales Guidance from BioMarin - Analyst Blog
2/19/2014 6:50:01 PM - Zacks.com

Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug - Analyst Blog
2/19/2014 10:27:01 AM - Zacks.com

Rare Early Success Of Ultragenyx Pharmaceuticals Could Continue With Expiration Of Quiet Period
2/18/2014 2:27:00 PM - Seeking Alpha

FDA Clears BioMarin's Vimizim - Analyst Blog
2/18/2014 1:10:01 PM - Zacks.com

BioMarin Bucks Biotech Short Interest Trend (BIIB, BMRN, MDVN)
2/13/2014 10:18:00 AM - Investopedia

UniQure IPO Could Heal What Ails Investors In 2014
2/4/2014 9:55:00 AM - Seeking Alpha

Ultragenyx Pharmaceuticals IPO Likely To Yield Investors Rewards
1/30/2014 9:55:00 AM - Seeking Alpha

BioMarin's Pipeline Encourages - Analyst Blog
1/23/2014 1:10:01 PM - Zacks.com

Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal - Analyst Blog
1/22/2014 2:01:01 PM - Zacks.com

Cramer's Lightning Round - Stay Long Kinder Morgan Partners (1/21/14)
1/22/2014 6:36:00 AM - Seeking Alpha

Pipeline Progress at BioMarin - Analyst Blog
1/15/2014 7:20:01 PM - Zacks.com

Celgene, Dendreon Lead Short Interest Trend In Biotechs (BMRN, CELG, DNDN)
1/11/2014 11:46:00 AM - Investopedia

Sector Update: Healthcare Shares Flat Pre-Market; Catalyst Pharmaceutical Partners Rises 14% on Joint Study of Firdapse Tablets
1/8/2014 9:56:51 AM - MT Newswires

Sector Update: Healthcare
1/8/2014 9:56:13 AM - MT Newswires

Notice of Allowance Received by Alkermes - Analyst Blog
1/7/2014 5:21:01 PM - Zacks.com

BioMarin Pharmaceutical Inc. (BMRN): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/3/2014 8:00:01 AM - Zacks.com

SA PRO: Top Long And Short Ideas, Tuesday December 24
12/25/2013 7:30:00 AM - Seeking Alpha

BioMarin: All Drivers Will Soon Be In Place For Explosive Growth - At Least 50% Upside
12/24/2013 9:45:00 AM - Seeking Alpha

Orphan Drug Designations: Why You Should Care
12/12/2013 10:23:00 AM - Seeking Alpha

Myriad, Janssen Partner on BRACAnalysis - Analyst Blog
12/10/2013 7:23:25 PM - Zacks.com